Member
This snapshot provides an overview of three treatments including Veklury (remdesivir), Eli Lilly’s bamlanivimab, and Regeneron’s antibody cocktail.
This document requests action to spur Congress to fully reinstate June reporting requirements for the COVID-19 Provider Relief Fund during its ‘lame-duck session.’
H-ISAC TLP Green: Coronavirus Daily Update - November 17, 2020
H-ISAC TLP Green: Daily Cyber Headlines November 17, 2020
An AHA Member Call on Allocation and Distribution of Operation Warp Speed (OWS) Therapeutics with Nancy Foster and John Redd, MD, CMO, ASPR, including remdesivir and monoclonal antibody (MAB) therapeutics like bamlanivimab through the Emergency Use Authorization (EUA).
Health-ISAC TLP Green: Daily Cyber Headlines - November 18, 2020
The AHA will host a call today, Nov. 16, from 4-5 p.m. ET with leaders from the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and other federal agencies to discuss the delivery and administration of monoclonal antibody therapies.
H-ISAC TLP Green: Coronavirus Weekend Recap, November 16, 2020
H-ISAC TLP Green: Coronavirus Daily Update, November 13, 2020
Today’s Headlines:
Leading Story